Use of the quantum dot-labeled solid lipid nanoparticles for delivery of streptomycin and hydroxychloroquine: A new therapeutic approach for treatment of intracellular Brucella abortus infection
Open Access
- 16 December 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 158, 114116
Abstract
No abstract availableKeywords
Funding Information
- Hamadan University of Medical Sciences (140003041705)
This publication has 32 references indexed in Scilit:
- Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trialInternational Journal of Antimicrobial Agents, 2018
- Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion techniqueColloids and Surfaces B: Biointerfaces, 2016
- Enhanced curcumin permeability by SLN formulation: The PAMPA approachLWT, 2016
- Risk Factors for Relapse of Human BrucellosisGlobal Journal of Health Science, 2015
- Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid NanoparticlesAAPS PharmSciTech, 2015
- Doxycycline delivery from PLGA microspheres prepared by a modified solvent removal methodJournal of Microencapsulation, 2012
- Drug delivery systems for potential treatment of intracellular bacterial infectionsFrontiers in Bioscience-Landmark, 2010
- TargetingBrucella melitensiswith polymeric nanoparticles containing streptomycin and doxycyclineFEMS Microbiology Letters, 2009
- Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune responseBiomaterials, 2007
- In Vitro Activities of Antibiotics Alone and in Combination against Brucella melitensis at Neutral and Acidic pHsAntimicrobial Agents and Chemotherapy, 1999